A breakthrough in cancer treatment is highlighted by the story of a woman who achieved remission for over 18 years after receiving CAR T-cell therapy for neuroblastoma as a child. This innovative therapy involves modifying a patient's T-cells to specifically target and eradicate cancer cells. While the success of CAR T-cell therapy has been notable for blood cancers, its efficacy in solid tumors has been less clear. The ongoing research and long-term follow-ups provide hope for future applications in treating various solid tumors.
The case of a woman who has been in remission for 18 years after CAR T-cell therapy showcases the potential of this approach in treating solid tumors, particularly neuroblastoma.
Researchers have reported the longest known survival after CAR T-cell therapy for an active cancer, highlighting the success of this approach even in early stages of development.
Collection
[
|
...
]